Skip to content

Clinical trials

Phase 1 Down Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Down Syndrome Phase: Phase 1 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20151
20161
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA1
Brigham and Women's Hospital1
HealthPartners Institute1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
Northwestern University1
University Hospitals Cleveland Medical Center1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Down Syndrome8
Alzheimer Disease2
Intellectual Disability2
Attention Deficit Disorder with Hyperactivity1
Cognitive Dysfunction1
Fragile X Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.